A previous report has also demonstrated that the promoter activity of GBAP1 was negligible through a CAT assay in the epithelial cell lines (HeLa or hepatoma cells) and a B cell line, prepared using a 650-bp SacI fragment, containing the original exon one as the promoter region7. The gene discussed is CAT; the disease is hepatocellular carcinoma.